会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Fusion proteins comprising cell cycle regulatory proteins
    • 包含细胞周期调节蛋白的融合蛋白
    • US5814503A
    • 1998-09-29
    • US770761
    • 1996-12-19
    • Steven KovacevicKeith A. OttoRamachandra N. Rao
    • Steven KovacevicKeith A. OttoRamachandra N. Rao
    • C07K14/47C12N9/12C12N15/52
    • C12N9/1205C07K14/4738
    • The present invention provides novel fusion proteins comprising cyclins and CDKs. A preferred embodiment of the invention provides fusion proteins comprising human cyclin D1 and human CDK4. The fusion proteins of the invention optionally contain modifications, which facilitate their purification. Addition of histidine residues to selected constructs allows purification via immobilized metal affinity chromatography. Antigenic determinants allowing monoclonal antibody-based affinity chromatography purification are provided in selected embodiments of the invention. Protease cleavage sites are incorporated in selected constructs to allow cleavage of the regions incorporated in the cyclin-CDK fusion proteins for purification. Additional modifications which facilitate purification include strepavadin binding domains and antigenic determinants for antibody affinity chromatography.
    • 本发明提供了包含细胞周期蛋白和CDK的新型融合蛋白。 本发明的优选实施方案提供包含人细胞周期蛋白D1和人CDK4的融合蛋白。 本发明的融合蛋白任选地含有有助于其纯化的修饰。 将组氨酸残基添加到选择的构建体允许通过固定的金属亲和层析进行纯化。 在本发明的选定实施方案中提供允许基于单克隆抗体的亲和层析纯化的抗原决定簇。 将蛋白酶切割位点并入选择的构建体中以允许切割结合在细胞周期蛋白-CDK融合蛋白中的区域进行纯化。 促进纯化的其它修饰包括用于抗体亲和层析的链脲霉素结合结构域和抗原决定簇。